SOURCE: Elsevier Business Intelligence

www.IN3West.com

January 04, 2010 09:30 ET

Global Medtech Companies and Medtech Investors Will Disclose Investment, M&A and Partnering Preferences at Elsevier's 'Medical Device Investor Day' in Las Vegas on March 3rd, 2010

Event Precedes 'IN3 West', the Largest Annual Strategic Partnership and Investment Meeting

LAS VEGAS, NV--(Marketwire - January 4, 2010) - Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, announced today that it will host 'Medical Device Investor Day' on March 3rd, 2010, at The Venetian Resort-Hotel-Casino, Las Vegas. This event is the prelude to 'IN3 West', also being held at The Venetian, on March 4-5, 2010.

Medical device start-ups face intense competition for a finite amount of available capital funding. IN3 events offer an unparalleled experience for emerging companies to meet and impress potential investors from many of the top-tier device companies and discerning healthcare investment firms from around the world.

"Medical Device Investor Day in Las Vegas will bring together early-, mid-, and late-stage medtech innovators along with the biggest medical device dealmakers in financing, partnering, and M&A," said David Cassak, Editor and Managing Director at Elsevier Business Intelligence. "Investor Day is critically important to medtech innovators interested in what the investment leaders in the space are looking for in terms of technologies, therapeutic areas, products, and geographic markets. They will specifically disclose partnering opportunities and how to maximize visibility in front of big-company investors, as well as discuss what the landscape for M&A is expected to look like in the new year."

Participants at the most recent Medical Device Investor Day, in San Francisco, included investors and corporate development executives from the following companies: Aberdare Ventures - Abingworth Management - Advanced Technology Ventures - Agate Medical Investments - Allergan - Alta Partners - Arboretum Ventures - Ascension Health Ventures - Baird Venture Partners - Becton Dickinson - Boston Scientific - C.R. Bard - CHL Medical Partners - Coronis Medical Ventures - Covidien Ventures - De Novo Ventures - Dow Chemical - Ethicon Endo-Surgery - Euclid SR Partners - Extera Partners - Frazier Healthcare Ventures - IDG Ventures - Johnson & Johnson - Kimberly-Clark - MB Venture Partners - Medtronic - Medventures Asso. - Montreux Equity Partners - New Leaf Venture Partners - Onset Ventures - Polaris Venture Partners - Prospect Venture Partners - PTV Sciences - SV Life Science - Safeguard Scientifics - Saints Capital - Sanderling Ventures - Sante Ventures Scale Venture Partners - Skyline Ventures - Stryker Corp. - Stryker Instruments - Synergy Life Science Partners - Teijin Pharma - Thomas, McNerney & Partners - US Venture Partners - Versant Ventures - Waveland Capital Partners - Wright Medical Technology.

Medical Device Investor Day will be followed by IN3 West on March 4-5, also at The Venetian Resort-Hotel, Las Vegas. IN3 West is the largest annual strategic partnership and investment meeting for senior-level medical technology executives. An audience of several hundred, including venture capital firms and other investors in the medtech industry are expected to attend IN3 West to hear about the latest innovations and investment opportunities from more than 50 emerging medical technology companies seeking funding and/or strategic partnerships.

For more information, please contact: Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.

Additional IN3 events in 2010: April 29-30: IN3 Europe, Paris: "Bridging European and U.S. Medical Device Innovators, Investors and Companies" (Marriott Rive Gauche Hotel). For more information, please contact: Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as Science Direct (www.sciencedirect.com), MDConsult (www.mdconsult.com), Nursing Consult (www.nursingconsult.com), Scopus (www.info.scopus.com), bibliographic databases, and online reference works.

Elsevier (www.elsevier.com) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (www.reedelsevier.com), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact Information